Article Details

Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with ... - BioNTech

Retrieved on: 2024-06-01 19:55:45

Tags for this article:

Click the tags to see associated articles and topics

Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with ... - BioNTech. View article details on hiswai:

Excerpt

COPENHAGEN, Denmark, and MAINZ, Germany, June 1, 2024 — Genmab A/S (Nasdaq: GMAB, “Genmab”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today ...

Article found on: investors.biontech.de

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo